Trial intelligence / Profile preview

PEG Bowel Protocol for Constipation in PD Patients

NCT03148002Phase 4Completed

Sponsor
Nova Scotia Health
Start
Jul 2017
Primary completion
Apr 2018
Modality
Injectable Hydrogels, Implantable Hydrogels, Biodegradable Polymers
Countries
1
01

Overview

A Phase 4 trial of polyethylene glycol 3350 in constipation, sponsored by Nova Scotia Health. Started Jul 2017; status: completed.

02

Drugs

polyethylene glycol 3350
03

Conditions

constipation

Beyond the preview

Go deeper on NCT03148002.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03148002.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call